Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-25

Clinical Trial Update: Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism [Phase 4]

View source ↗

Summary

A Phase 4 trial compares chronic olanzapine versus risperidone and assesses their effects on glucose and lipid metabolism in schizophrenia patients, highlightin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Risperdal (risperidone)
  • Zyprexa (olanzapine)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia, Diabetes | Phase 4 | Status: COMPLETED